Trial · NCT03953326
HeartPhone Cancer Survivors Trial 2019
NCT03953326, Phase 1, Phase 2, Terminated, Penn State University; results first posted 2026-02-27
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. HeartPhone Cancer Survivors Trial 2019. Trials, record NCT03953326. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03953326
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- HeartPhone Cancer Survivors Trial 2019
- NCT number
- NCT03953326
- Status
- Terminated
- Phases
- Phase 1, Phase 2
- Enrollment
- 2 participants, actual
- Lead sponsor
- Penn State University
- Conditions
- Breast Cancer, Leukemia, Lymphoma
- Interventions
- HeartPhone app, Acetylcholine, Sodium Nitroprusside, L-Arginine, N2-((4-Methylphenyl)Sulfonyl)-, Methyl Ester
- First posted
- 2019-05-16
- Last updated
- 2026-02-27
- Results first posted
- 2026-02-27
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Installation of the Heartphone Application. | 3 months | Change in the total physical activity volume from baseline to 3 months as measured by the Actigraph GT3XP-BTLE (total activity counts) |
| Primary | Installation of the Heartphone Application. | 6 months | Change in the total physical activity volume from baseline to 3 and 6 month as measured by the Actigraph GT3XP-BTLE (total activity counts). |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Installation of the Heartphone Application. | 3 months | Only one participant completed 3 month assessment and the study was terminated early due to futility in enrollment. | Change in average daily activity counts | NUMBER |
| PRIMARY | Installation of the Heartphone Application. | 6 months | Study was terminated prematurely due to futility in recruitment. No participants completed the 6 months assessment. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Installation of the Heartphone Application. | HeartPhone Intervention | 21155.05 | Change in average daily activity counts | ||
| Installation of the Heartphone Application. | HeartPhone Intervention | 0 | Participants |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | HeartPhone Intervention | 2 | |
| Overall Study | COMPLETED | HeartPhone Intervention | 0 | |
| Overall Study | NOT COMPLETED | HeartPhone Intervention | 2 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | HeartPhone Intervention | 0 | 2 |
| Total, other adverse events | HeartPhone Intervention | 0 | 2 |
| Total, serious adverse events | HeartPhone Intervention | 0 | 2 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03953326
GET https://conductscience.org/api/trials/v1/NCT03953326/registered